Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase NA 1

Status

Recruiting 13Terminated 5Not yet recruiting 5Unknown 4Active not recruiting 4Completed 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Resectable Non-small Cell Lung Cancer 1Ovarian Cancer Recurrent 1NSCLC 1Lymphatic Metastasis 1Esophageal Squamous Cell Carcinoma 1Carcinoma 1

Interventions

Carboplatin 34Pemetrexed 27Drug Therapy 22Cisplatin 22osimertinib 18aflutinib 11Paclitaxel 11pembrolizumab 10Surgical Procedures, Operative 10Docetaxel 10tislelizumab 9Radiotherapy 8Magnetic Resonance Spectroscopy 8anlotinib 7Specimen Handling 7Bevacizumab 7130-nm albumin-bound paclitaxel 7toripalimab 6cemiplimab 6Immunotherapy 6sintilimab 5ensartinib 5durvalumab 5Radiosurgery 5Platinum Compounds 5Nivolumab 5trametinib 4aumolertinib 4Observation 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Non-Small-Cell Lung × Platinum Compounds × Clear all
NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Tang-Du Hospital

Phase NA Not yet recruiting
28 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

Shanghai JMT-Bio Inc.

Phase 1/2 Not yet recruiting
596 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07063329 2025-07-25

Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive

Avistone Pharmaceutical(Ningbo)Co., LTD.

Phase 1/2 Not yet recruiting
108 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06908733 2025-04-03

Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC

Liaoning Cancer Hospital & Institute

Phase 2 Not yet recruiting
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06614231 2024-09-26

Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer

Sun Yat-sen University

Phase 2 Not yet recruiting
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡